Track Procept BioRobotics's total assets ($490M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Procept BioRobotics's total assets stands at $490M as of March 2026. That compares with $520M in the prior-year period — down 6.2% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Procept BioRobotics reported $490M in total assets versus $520M a year earlier — a 6.2% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
That compares with $520M in the prior-year period — down 6.2% year over year. Sustained growth in total assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.
The history chart shows how Procept BioRobotics's total assets evolved across reporting periods, while the comparison chart places PRCT next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, total assets is commonly used to spot outliers. Procept BioRobotics's reading of $490M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.